Thu, September 20, 2012
Wed, September 19, 2012
Tue, September 18, 2012
Mon, September 17, 2012
Sun, September 16, 2012
Fri, September 14, 2012
Thu, September 13, 2012
Wed, September 12, 2012
Tue, September 11, 2012
Mon, September 10, 2012
Sun, September 9, 2012
Fri, September 7, 2012
Thu, September 6, 2012
Wed, September 5, 2012
Tue, September 4, 2012

Sequenom Announces Participation At Two Upcoming Investor Conferences


//health-fitness.news-articles.net/content/2012/ .. pation-at-two-upcoming-investor-conferences.html
Published in Health and Fitness on Wednesday, September 12th 2012 at 4:17 GMT by Market Wire   Print publication without navigation


Sequenom Announces Participation At Two Upcoming Investor Conferences -- SAN DIEGO, Sept. 12, 2012 /PRNewswire/ --

Sequenom Announces Participation At Two Upcoming Investor Conferences

[ ]
[ ]

SAN DIEGO, Sept. 12, 2012 /PRNewswire/ --  Sequenom, Inc. (NASDAQ: [ SQNM ]), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Lazard Capital Markets Corporate Access Day in Boston, Mass., and the Credit Suisse 3rd Annual Small and Mid-Cap Conference, in New York.  

On Tuesday, September 18, Ronald M. Lindsay, Ph.D., Director and EVP of Research and Development, will participate in the Lazard Capital Markets Corporate Access Day.  

Then, on Thursday, September 20, Dr. Lindsay will present at the Credit Suisse Small and Mid-Cap Conference, starting at 1:50 pm ET and will provide an overview of and update on the Company. The presentation is expected to last approximately 30 minutes and will be webcast live through the "Investors" section of the Sequenom website at [ www.sequenom.com ]. An audio replay will be available for 30 days following the initial presentation webcast.  

About Sequenom
Sequenom, Inc. (NASDAQ: [ SQNM ]) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at [ http://www.sequenom.com ] to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.

(Logo:  [ http://photos.prnewswire.com/prnh/20040415/SQNMLOGO ])

SOURCE Sequenom, Inc.



[ Back to top ]

RELATED LINKS
[ http://www.sequenom.com ]


Publication Contributing Sources